HTD.BE - CORCEPT THERAPEUTICS INC.

Berlin - Berlin Delayed Price. Currency in EUR
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2018
12/31/2017
12/31/2016
Total Revenue
285,422
251,247
159,201
81,321
Cost of Revenue
5,647
5,215
3,554
2,058
Gross Profit
279,775
246,032
155,647
79,263
Operating Expenses
Research Development
83,499
75,247
40,376
23,844
Selling General and Administrative
94,788
81,289
62,416
45,240
Total Operating Expenses
178,287
156,536
102,792
69,084
Operating Income or Loss
101,488
89,496
52,855
10,179
Interest Expense
-
-
49
2,039
Total Other Income/Expenses Net
-
-
-
0
Income Before Tax
106,156
92,153
52,806
8,140
Income Tax Expense
19,348
16,743
-76,316
-
Income from Continuing Operations
86,808
75,410
129,122
8,140
Net Income
86,808
75,410
129,122
8,140
Net Income available to common shareholders
86,808
75,410
129,122
8,140
Reported EPS
Basic
-
0.65
1.14
0.07
Diluted
-
0.60
1.04
0.07
Weighted average shares outstanding
Basic
-
115,343
113,527
110,566
Diluted
-
126,688
124,515
116,139
EBITDA
-
89,496
52,855
10,266